基于 2 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the complete record of transactions filed by Gilad Oren. Insider active across 1 company, notably Aprea Therapeutics, Inc.. In total, 12 filings have been logged. Split: 7 buys · 0 sell. Total volume traded: €45k. Activity tracked since 28 July 2022. The latest transaction was filed on 12 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Gilad Oren is a declarant linked to Aprea Therapeutics, Inc. on XNAS, where the listed role is President/CEO. He has 12 filings in total, and within the sampled recent filings there are €44,532 of buys and €0 of sells, with activity spanning from 2022-08-01 to 2026-03-16, and the modal transaction nature is Acquisition.